Egret Therapeutics Appoints Dr. Geoffrey Ling to Scientific Advisory Board - Advancing its Mission to Address Critical Military Health Needs

Egret Therapeutics, a portfolio company of Turret Capital Management, is a clinical stage biotechnology company focused on function preservation following acute injuries NEW YORK, July 14, 2025 /PRNewswire/ -- Egret Therapeutics today announced the appointment of Dr. Geoffrey Ling, MD,...